Urgently Enrolling

Urgently Enrolling

See if you qualify

Cutting-Edge Type 1 Diabetes Study

Locations: Manhattan and Long Island City

Cost to you: none for study visits, tests, or study medication

Questions: 516-574-9232 · Hablamos español

  • This clinical study is exploring whether an investigational study drug can help preserve the body’s ability to make insulin and reduce the need for daily insulin therapy, while keeping blood glucose levels within acceptable limits.

    • Participant must be between the ages of 1 and 25

    • Participant must have received diagnosis of Type One Diabetes very recently*.

    (*within the past 2 months prior to submission)

  • Gain access to cutting-edge medications before they are widely available.

A boy receiving a vaccination from a healthcare professional in a clinical setting.

Pre-screen for this study

Answer a few questions and a study coordinator will call you to go over the next steps. Your information is used only to contact you about this study.